Towards Healthcare
Clinical Trial Software Market
Updated Date: 01 November 2025   |   Report Code: 6132
sales@towardshealthcare.com +1 804-441-9344
Download Sample Order Now

Clinical Trial Software Market Boosted by Decentralized Trials

Based on market forecasts, the global clinical trial software market, projected at USD 0.9 billion in 2024, is expected to reach USD 3.23 billion by 2034, growing at a CAGR of 13.74% over the forecast period. The market is growing due to rising demand for digital tools that streamline trial design, data management, and regulatory compliance. Additionally, the surge in decentralized and virtual trials is accelerating the adoption of software solutions.

Last Updated : 01 November 2025 Category: Healthcare IT Insight Code: 6132 Format: PDF / PPT / Excel

Content

TOC is not Available for this Report

FAQ's

Answer : The clinical trial software market is worth USD 1.03 billion in 2025, and by 2034, it is forecasted to hit USD 3.23 billion, registering a CAGR of 13.74% over the decade.

Answer : North America is currently leading the clinical trial software market due to the region hosting a high concentration of contract research organizations (CROs) and technology-driven life sciences firms.

Answer : Some key players include Medable, Signant Health, Clario, OmniComm Systems, Castor EDC, and Medrio.  
Any Questions

Meet the Team

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and strategy.

Learn more about Shivani Zoting

Aditi Shivarkar is a seasoned professional with over 14 years of experience in healthcare market research. As a content reviewer, Aditi ensures the quality and accuracy of all market insights and data presented by the research team.

Learn more about Aditi Shivarkar
WhatsApp